Valneva initiates heterologous booster trial of inactivated, COVID-19 vaccine candidate
Valneva, a specialty vaccine company, today announced the initiation of a heterologous booster trial of its inactivated whole-virus COVID-19 vaccine... View Article
iSRS 2022 International Symposium on Radiopharmaceutical Sciences | A gathering of world-renowned experts in radiopharmaceutical sciences in Nantes
From 29th May to 2nd June 2022, around 400 researchers from the world over will gather at the Cité des... View Article
Valneva receives conditional marketing authorization from UK MHRA for its inactivated COVID-19 vaccine
Valneva, a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom... View Article
Transplantation & immunology | Parean Biotechnologies joins a European consortium funded by Horizon Europe
Parean Biotechnologies is officially partner and consortium member, of Horus Project ! This new approved 7+ Million Euros project, funded by... View Article
New member | SIB
Leading digital cooperative actor serving the public sector, the French public benefit corporation SIB is an expert in conception, deployment,... View Article
New member | BA Healthcare
BA Healthcare, a company based in Rennes and created in 2011, specializes in the design and mass production of medical... View Article
Cluster-to-business knowledge transfer
To strengthen SMEs and start-ups from partnering clusters, the Pitch Coaching Training was organised to expose SMEs to the specific... View Article
Transnational missions (C2C exchanges)
The CE4BIG project (Cluster Excellence for Business, Innovation and Growth in the health sector), supported by the EU COSME Programme,... View Article
InFlectis BioScience granted Orphan Drug Designation for IFB-088 (icerguastat), a clinical stage treatment for Amyotrophic Lateral Sclerosis
IFB-088 has been granted Orphan-Drug Designation from the FDA in the treatment of Amyotrophic Lateral Sclerosis (ALS). IFB-088 is a... View Article
Promega Corporation and FUJIFILM Cellular Dynamics announce strategic collaboration to advance novel assay development
New licensing agreement will deliver luminescent reporter technology into iPSCs Promega Corporation (Promega), a leader in providing innovative solutions and technical... View Article